Navigation Links
Johns Hopkins scientists pull protein's tail to curtail cancer
Date:12/30/2008

When researchers look inside human cancer cells for the whereabouts of an important tumor-suppressor, they often catch the protein playing hooky, lolling around in cellular broth instead of muscling its way out to the cells' membranes and foiling cancer growth.

This phenomenon of delinquency puzzled scientists for a long time until a cell biologist in the Johns Hopkins University School of Medicine felt compelled to genetically grab the protein by the tail and then watched as it got back to work at tamping down disease.

"It was curious that when we removed its tail, the protein suddenly was unhindered and moved out to the membrane and became active," says Meghdad Rahdar, a graduate student in pharmacology.

The discovery, published Dec. 15 online at the Proceedings of the National Academy of Sciences, represents a potential new approach to cancer therapy, according to Peter Devreotes, Ph.D., professor and director of cell biology at Johns Hopkins.

"A long-term goal is to find a drug that does the equivalent of our bit of genetic engineering," he says.

The flexible tail contains a cluster of four amino acids the building blocks of proteins that regulate this tumor suppressor known as PTEN. When chemically modified, these amino acids act to "glue" the tail back to the body of PTEN and prevent the attachment of PTEN to the membrane. By genetically removing PTEN's tail, or manipulating the cluster of four amino acids so that they cannot be modified, the researchers persuaded PTEN to move to the cell membrane where it goes about its tumor-suppressing business of degrading a molecular signal called PIP3 that causes errant cell growth.

"As far as I know, I haven't seen anyone activate a tumor suppressor, but we seem to have done it genetically," Rahdar says.

While genetically engineering cancer cells in the human body is neither practical nor safe, manipulating such unbinding of PTEN wit
'/>"/>

Contact: Maryalice Yakutchik
myakutc1@jhmi.edu
443-287-2251
Johns Hopkins Medical Institutions
Source:Eurekalert

Page: 1 2

Related biology news :

1. Johns Hopkins researchers detect sweet cacophony while listening to cellular cross-talk
2. Johnson & Johnson honors 2008 recipients of the Dr. Paul Janssen Award for Biomedical Research
3. Johns Hopkins scientists discover what drives the development of a fatal form of malaria
4. Grant to fund answers about St. Johns River
5. Hopkins researchers piece together gene network linked to schizophrenia
6. Worth a thousand words: Hopkins researchers paint picture of cancer-promoting culprit
7. Vaginal reconstruction not needed for most inter-sex females, Hopkins study shows
8. Trees wont stop tsunamis, scientists warn
9. UCSB scientists show how certain vegetables combat cancer
10. Hebrew University scientists reveal mechanism that triggers differentiation of embryo cells
11. Haag honored with Presidential Early Career Scientists Award
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/15/2010)... Plasmodium vivax ( P. vivax ) malaria ... be resistant to the disease, those who do not ... blood cells, according to researchers from Case Western Reserve ... Ministry of Health. In a study of more than ... transmission areas of Madagascar, the researchers found that 10 ...
(Date:3/15/2010)... with a cup of steaming hot coffee. Although ... brew," coffee contains several nutrients (eg, calcium) as ... (eg, polyphenols) that may promote health. For instance, ... coffee consumption and type 2 diabetes. Determining whether ... controlled intervention trials. Two articles published in the ...
(Date:3/15/2010)... This release is available in Spanish . ... a healthy weight before they become pregnant, and to ... pregnancy. Now ongoing studies by Agricultural Research Service (ARS)-funded ... insights into those recommendations. , Shankar is ... occur in the womband perhaps during the first few ...
Breaking Biology News(10 mins):Duffy-negative blood types no longer protected from P. Vivax malaria 2Duffy-negative blood types no longer protected from P. Vivax malaria 3Baby's obesity risk: What's the mother's influence? 2Bird flu leaves the nest adapting to a new host 9699 1Hill Rom to Participate at the Thomas Weisel Partners 2009 Healthcare Conference 55399 1Hill Rom to Participate at the Thomas Weisel Partners 2009 Healthcare Conference 55399 2Versa Card Inc Opens First Treatment Center for Spine Pain Management Inc 55395 1Versa Card Inc Opens First Treatment Center for Spine Pain Management Inc 55395 2
... has successfully protected mice and ferrets against a highly ... led the study at St. Jude Children's Research Hospital. ... Diego, California. , This finding, coupled with results of ... strains, suggests that such a vaccine would protect humans ...
... To study the bacteria which survive in extreme cold, ... such as Antarctic lakes and glaciers. Bacteria previously isolated ... to survive in extreme cold, have been isolated from ... her colleagues at Queen's University, Canada, have developed a ...
... that generate the strongest immune response in mice, ... a vaccine that significantly protects immunized animals from ... most common cause of hospital-acquired infections and a ... The vaccine protected mice against potentially lethal infections ...
Other Biology News:St. Jude test of bird flu vaccine proves successful 2MRSA vaccine shows promise in mouse study 2MRSA vaccine shows promise in mouse study 3
(Date:3/15/2010)... YORK , March 15 /PRNewswire-Asia-FirstCall/ -- NeoStem, Inc.,(NYSE Amex: NBS ... and China , announced,today a change for the Company,s presentation at the ... 15, 2010 .,NeoStem,s presentation will now take place at 10:30 a.m. Pacific ... ... ...
(Date:3/15/2010)... YORK , March 15 /PRNewswire-Asia-FirstCall/ -- American Oriental,Bioengineering, Inc. (NYSE: ... improving health through the development, manufacture and,commercialization of a broad range of ... fourth quarter and fiscal,year ended December 31, 2009 . ,, ... ... ...
(Date:3/14/2010)... , March 14 /PRNewswire/ -- Results from a landmark study involving more than 9,000 people showed that the high blood ... condition. , ... , , ... ... ...
(Date:3/12/2010)... Vermillion, Inc. (Pink Sheets: VRML) today announced that Medicare will ... mass is benign or malignant. Highmark Medicare Services is the CMS contractor ... to cover this new service. , ... ... ...
Breaking Biology Technology:NeoStem Announces Presentation Time Change at Roth Capital Partners 22nd Annual OC Growth Stock Conference 2NeoStem Announces Presentation Time Change at Roth Capital Partners 22nd Annual OC Growth Stock Conference 3American Oriental Bioengineering Reports Fourth Quarter and Full Year 2009 Financial Results 2American Oriental Bioengineering Reports Fourth Quarter and Full Year 2009 Financial Results 3American Oriental Bioengineering Reports Fourth Quarter and Full Year 2009 Financial Results 4American Oriental Bioengineering Reports Fourth Quarter and Full Year 2009 Financial Results 5American Oriental Bioengineering Reports Fourth Quarter and Full Year 2009 Financial Results 6American Oriental Bioengineering Reports Fourth Quarter and Full Year 2009 Financial Results 7American Oriental Bioengineering Reports Fourth Quarter and Full Year 2009 Financial Results 8American Oriental Bioengineering Reports Fourth Quarter and Full Year 2009 Financial Results 9American Oriental Bioengineering Reports Fourth Quarter and Full Year 2009 Financial Results 10American Oriental Bioengineering Reports Fourth Quarter and Full Year 2009 Financial Results 11American Oriental Bioengineering Reports Fourth Quarter and Full Year 2009 Financial Results 12NAVIGATOR Shows Valsartan Delayed Progression to Type 2 Diabetes in At-Risk Cardiovascular Patients With Impaired Glucose Tolerance 2NAVIGATOR Shows Valsartan Delayed Progression to Type 2 Diabetes in At-Risk Cardiovascular Patients With Impaired Glucose Tolerance 3NAVIGATOR Shows Valsartan Delayed Progression to Type 2 Diabetes in At-Risk Cardiovascular Patients With Impaired Glucose Tolerance 4NAVIGATOR Shows Valsartan Delayed Progression to Type 2 Diabetes in At-Risk Cardiovascular Patients With Impaired Glucose Tolerance 5NAVIGATOR Shows Valsartan Delayed Progression to Type 2 Diabetes in At-Risk Cardiovascular Patients With Impaired Glucose Tolerance 6NAVIGATOR Shows Valsartan Delayed Progression to Type 2 Diabetes in At-Risk Cardiovascular Patients With Impaired Glucose Tolerance 7NAVIGATOR Shows Valsartan Delayed Progression to Type 2 Diabetes in At-Risk Cardiovascular Patients With Impaired Glucose Tolerance 8NAVIGATOR Shows Valsartan Delayed Progression to Type 2 Diabetes in At-Risk Cardiovascular Patients With Impaired Glucose Tolerance 9NAVIGATOR Shows Valsartan Delayed Progression to Type 2 Diabetes in At-Risk Cardiovascular Patients With Impaired Glucose Tolerance 10NAVIGATOR Shows Valsartan Delayed Progression to Type 2 Diabetes in At-Risk Cardiovascular Patients With Impaired Glucose Tolerance 11NAVIGATOR Shows Valsartan Delayed Progression to Type 2 Diabetes in At-Risk Cardiovascular Patients With Impaired Glucose Tolerance 12NAVIGATOR Shows Valsartan Delayed Progression to Type 2 Diabetes in At-Risk Cardiovascular Patients With Impaired Glucose Tolerance 13Medicare Establishes Reimbursement Coverage for Vermillion's OVA1(TM) Test 2Medicare Establishes Reimbursement Coverage for Vermillion's OVA1(TM) Test 3Medicare Establishes Reimbursement Coverage for Vermillion's OVA1(TM) Test 4
... MannKind Corporation (Nasdaq: MNKD ), focused on ... announced today that it will present at the 11th ... on Monday, February 9, 2009 at 2:15 PM (EST) ... In addition to this presentation, the Company ...
... genetic materialSAN DIEGO, Feb. 2 Following three years ... veterans today announced the formation of SG Biofuels ... in the development of Jatropha as a low-cost, sustainably ... Chief Executive Officer, introduced the company at the 2009 ...
... To highlight its 20 years of experience as ... ( www.microtestlabs.com ) is offering free microbial identification ... tests, to eligible attendees visiting the Microtest exhibit, #828, ... highlight Microtest,s wide range of laboratory testing and validation ...
Other Biology Technology:MannKind to Present at the 11th Annual Biotechnology Industry Organization BIO CEO & Investor Conference 2Energy, Biotechnology and Agribusiness Veterans Form SG Biofuels to Develop Jatropha as Low-Cost, Sustainable Oil 2Microtest Labs Offers Free Microbial Identification Testing, Free Shipping on Other Tests, to MD&M West Attendees 2
... Re-Blot Western Blot Recycling Kit is ... Western blots that have been developed ... other isotopes. It is not recommended ... 4-chloronapthol, etc.), as it is not ...
... Immulon ... surface to provide increased binding affinity ... Flat bottom works well for ... optical characteristics., Each ...
Ethylene glycol-bis(2-aminoethyl ether)-N,N,N',N'-tetraacetic acid, Molecular Biology Grade...
... relax positively and negatively supercoiled DNA in presence ... Studying the effects of supercoiling on transcription in ... , Determining the degree of supercoiling of ... that differ in length by only one base-pair ...
Biology Products: